Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 541 - 550 of 785 studies

Respiratory

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Proof of Concept (POC) Study Evaluating the Safety, Tolerability, and Efficacy of Nintedanib Solution for Inhalation (AP02) in Participants with Idiopathic Pulmonary Fibrosis (IPF) (AURA-IPF).

Cancer and neoplasms

A PHASE II, RANDOMIZED, OPEN-LABEL STUDY EVALUATING TWO INAVOLISIB DOSE LEVELS IN COMBINATION WITH FULVESTRANT IN PARTICIPANTS WITH PIK3CA-MUTATED, HR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER (WO46063 (optINAVO))

Inflammatory and immune system

Platform Open-label Interventional Biomarker Study of Targeted Therapies for the Treatment of Adult Subjects with Rheumatoid Arthritis.

Oral and Gastrointestinal

Trial to Evaluate Safety, Tolerability, PK, and Mechanism of Action of Zasocitinib in Participants With Moderately-to-Severely Active Crohn’s Disease (ZODIAC)

Oral and Gastrointestinal

A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes) (N1T-MC-MALO (SYNERGY-Outcomes))

Neurological

A phase 1 single ascending dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SRP-1005 in subjects with Huntington’s Disease (INSIGHTT)

Blood

A MULTICENTER, RANDOMIZED, OPEN‑LABEL, PHASE III CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF NXT007 PROPHYLAXIS VERSUS FACTOR VIII PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A WITHOUT INHIBITORS (ZEBRHA-1)

Biopsy Investigation of Oxford Synovitis Cohort

An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Single Dose of ANX005 in Participants With Guillain-Barré Syndrome. (FORWARD)

Natural history and standards of care in Duchenne Muscular Dystrophy - The U.K. NorthStar Clinical Network.